Terms: = Breast cancer AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18 AND Clinical Outcome
4 results:
1. Patterns of copy number alterations in primary breast tumors of South African patients and their impact on functional cellular pathways.
Lupicki K; Elifio-Esposito S; Fonseca AS; Weber SH; Sugita B; Langa BC; Pereira SRF; Govender D; Panieri E; Hiss DC; Abdul-Rasool S; Cavalli LR
Int J Oncol; 2018 Dec; 53(6):2745-2757. PubMed ID: 30320392
[TBL] [Abstract] [Full Text] [Related]
2. Ginsenoside Rd attenuates breast cancer metastasis implicating derepressing microRNA-18a-regulated smad2 expression.
Wang P; Du X; Xiong M; Cui J; Yang Q; Wang W; Chen Y; Zhang T
Sci Rep; 2016 Sep; 6():33709. PubMed ID: 27641158
[TBL] [Abstract] [Full Text] [Related]
3. Asporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in breast cancer.
Maris P; Blomme A; Palacios AP; Costanza B; Bellahcène A; Bianchi E; Gofflot S; Drion P; Trombino GE; Di Valentin E; Cusumano PG; Maweja S; Jerusalem G; Delvenne P; Lifrange E; Castronovo V; Turtoi A
PLoS Med; 2015 Sep; 12(9):e1001871. PubMed ID: 26327350
[TBL] [Abstract] [Full Text] [Related]
4. Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitors.
Martinez-Outschoorn UE; Pavlides S; Whitaker-Menezes D; Daumer KM; Milliman JN; Chiavarina B; Migneco G; Witkiewicz AK; Martinez-Cantarin MP; Flomenberg N; Howell A; Pestell RG; Lisanti MP; Sotgia F
Cell Cycle; 2010 Jun; 9(12):2423-33. PubMed ID: 20562526
[TBL] [Abstract] [Full Text] [Related]
